PARIS, France – December 17, 2025 – 10:05 pm CET – Abivax SA (Euronext Paris: FR0012333284 – ABVX / Nasdaq: ABVX) ("Abivax" or the "Company"), a clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases, today announced that 22 scientific abstracts detailing advancements in the understanding of obefazimod for the treatment of inflammatory bowel disease (IBD) wil ...

EPA-Certified reclaimer and refrigerant distributor expands recovery network and geographic footprint WOODCLIFF LAKE, N.J., Dec. 17, 2025 (GLOBE NEWSWIRE) -- Hudson Technologies, Inc. (NASDAQ: HDSN) a leading provider of innovative and sustainable refrigerant products and services to the Heating, Ventilation, Air Conditioning and Refrigeration Industry – and one of the nation's largest refrigerant reclaimers - has announced the acquisition of Refrigerants Inc., an EPA- certified reclaimer and refrigerant di ...

The Company intends to actively monitor the closing bid price of its Class A ordinary shares and is considering all available options to regain compliance with the Minimum Bid Price Requirement and maintain its Nasdaq listing. These options may include, among other things, effecting a reverse stock split. About Haoxin Holdings Limited Haoxin Holdings Limited is a provider of temperature-controlled truckload transportation services and urban delivery services in China. The Company primarily provides transpor ...

invest@parksamerica.com John Grau InvestorCom (203) 972-9300 info@investor-com.com Additional information, including our Annual Report on Form 10-K for the fiscal year ended September 28, 2025, is available in the Investor Info section of the Company's website, www.parksamerica.com. Cautionary Note Regarding Forward Looking Statements This news release may contain "forward-looking statements" within the meaning of U.S. securities laws. Forward-looking statements include statements concerning the Company's f ...

SOUTH SAN FRANCISCO, Calif., Dec. 17, 2025 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a clinical-stage oncology company pioneering site-specific and novel- format antibody drug conjugates (ADCs), today announced it has regained compliance with the Nasdaq Stock Market (Nasdaq) continued listing standard for minimum share price under Rule 5450(a)(1) of the Nasdaq Listing Qualifications. On December 17, 2025, the Company received confirmation from the Listing Qualification ...

– End-of-Phase 2 interactions with FDA complete; scientific advice received from EMA – NEW YORK, Dec. 17, 2025 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a late- stage clinical oncology company focused on keeping cancer patients alive and helping them thrive, today announced that it is on track to dose the first patient in its planned global Phase 3 registrational trial in first line pancreatic cancer patients in mid-2026, evaluating atebimetinib (320 mg QD) in combination with modified gem ...

Daix (France), New York City (New York, United States), December 17, 2025 – Inventiva (Euronext Paris and NASDAQ: IVA) ("Inventiva" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of oral therapies for the treatment of metabolic dysfunction-associated steatohepatitis ("MASH"), today announced that CEO Andrew Obenshain has been invited to present a corporate overview, and will engage with Inventiva's leadership team in investor meetings, at the upcoming 44 Annual J.P. ...

The Company is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The Company may pursue an acquisition opportunity in any business or industry or at any stage of its corporate evolution. The Company's primary focus, however, will be to identify companies in the technology, real assets, and energy sectors. The Company's management team is led by Jonathan Z. Cohen, i ...

NEW YORK, Dec. 17, 2025 (GLOBE NEWSWIRE) -- Xcel Brands, Inc. (NASDAQ: XELB) (“Xcel” or the “Company”), announces today that it has entered into a securities purchase agreement for a private investment in public equity (“PIPE”) financing that is expected to result in gross proceeds to the Company of approximately $2.05 million, before deducting placement agent fees and offering expenses. The Company intends to use the net proceeds from the offering for general corporate purposes and working capital. Pursuan ...

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, Dec. 17, 2025 (GLOBE NEWSWIRE) -- Copper Road Resources Inc. (TSX-V: CRD) ("Copper Road" or the "Company") announces today that due to investor demand it is increasing the offering size of its non-brokered private placement as previously announced on December 12, 2025 and December 17, 2025. The upsized offering (the “Offering”) will consist of the sale of up to: (i) 9,997,143 common share units in the ...